About this trial
This study aims to compare how well two different types of fetal growth charts work in tracking the growth of twins during pregnancy. These charts help doctors decide if a fetus is growing normally. One type is commonly used for all pregnancies, while the other is specially designed for twin pregnancies. The study will enroll pregnant individuals carrying twins. Participants will be randomly assigned to have their care guided by either the traditional chart or the twin-specific chart. Researchers will compare outcomes such as birth weight, timing of delivery, and newborn health. The goal is to find out if using twin-specific charts can improve care and reduce unnecessary interventions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnant individuals with a twin pregnancy of at least 18 weeks gestation.
Willing and able to provide informed consent.
Planning to deliver at a participating center.
Disqualifiers
Major fetal anomalies or known aneuploidy.
Significant maternal medical conditions that might confound study outcomes.
Inability to comply with study procedures.
Trial design
Parallel
Treatments tested in this trial
Twin-Specific Growth Chart Interpretation
Other interventionParticipants in this arm will have their fetal growth assessed using twin-specific growth charts. These charts account for twin gestation norms and may influence clinical decision-making regarding growth restriction and perinatal management. The intervention does not involve any direct physical procedure or device but rather a change in the interpretation framework of routinely collected ultrasound data.
Singleton-Based Growth Chart Interpretation
Other interventionParticipants in this arm will have their fetal growth assessed using singleton-based growth charts. These charts are commonly used in standard practice but may overestimate growth restriction in twin pregnancies. The intervention does not involve any direct physical procedure or device but alters the interpretation framework for standard prenatal ultrasound findings.
Treatment groups
Trial outcomes
Primary outcomes
Rate of Small for Gestational Age (SGA) Diagnosis Based on Ultrasound Biometry
The primary outcome is the incidence of small for gestational age (SGA) diagnosis among twin pregnancies, as determined by fetal biometry assessed during prenatal ultrasound using either twin-specific or singleton-based growth charts. SGA is defined as an estimated fetal weight below the 10th percentile for gestational age according to the respective chart used in each study arm.
Secondary outcomes
Rate of Neonatal Composite Morbidity
Composite includes one or more of the following: CPAP use \>72 hours, intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), neonatal hypoglycemia requiring IV therapy, or neonatal death.
Rate of NICU Admission
Percentage of neonates admitted to the Neonatal Intensive Care Unit (NICU) following delivery, as documented in clinical records.
Birthweight Discordance Between Twins
Defined as the percentage difference in birthweight between the two fetuses in each twin pair. Discordance \>20% will be considered clinically significant.
Gestational Age at Delivery
Measured in completed weeks of gestation at the time of birth, based on clinical and ultrasound dating.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: